Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Double-Blind, Placebo-Controlled Trial of Leptin Replacement Therapy in Patients With Lipodystrophy

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00896298
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:39:52.299668+00:00
Published At
2019-03-05T00:00:00+00:00
Record Updated At
2024-03-27
Results Posted At
2019-03-05
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Hypoleptinemia", "Generalized Lipodystrophy", "Partial Lipodystrophy", "Insulin Resistance"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2024-03-27"
protocolSection.identificationModule.nctId
"NCT00896298"
protocolSection.identificationModule.officialTitle
"Double-Blind, Placebo-Controlled Trial of Leptin Replacement Therapy in Patients With Lipodystrophy"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE2", "PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2019-03-05"

Study condition terms

  • Hypoleptinemia (protocolSection.conditionsModule.conditions)
  • Generalized Lipodystrophy (protocolSection.conditionsModule.conditions)
  • Partial Lipodystrophy (protocolSection.conditionsModule.conditions)
  • Insulin Resistance (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.